5/2
05:07 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/2
05:07 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/1
08:19 am
aktx
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics [Yahoo! Finance]
High
Report
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics [Yahoo! Finance]
5/1
08:19 am
aktx
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity [Yahoo! Finance]
High
Report
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity [Yahoo! Finance]
5/1
08:01 am
aktx
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
Medium
Report
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
5/1
08:00 am
aktx
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
Medium
Report
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
5/1
08:00 am
aktx
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
Medium
Report
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
4/24
02:12 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/16
02:08 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/15
08:13 am
aktx
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024 [Yahoo! Finance]
Low
Report
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024 [Yahoo! Finance]
4/15
08:00 am
aktx
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
Low
Report
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
4/8
02:07 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/1
01:30 pm
aktx
Akari Therapeutics Insider Ups Holding By 69% During Year [Yahoo! Finance]
Neutral
Report
Akari Therapeutics Insider Ups Holding By 69% During Year [Yahoo! Finance]
4/1
06:36 am
aktx
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights [Yahoo! Finance]
High
Report
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights [Yahoo! Finance]
4/1
06:30 am
aktx
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
High
Report
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
3/31
02:09 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/23
02:10 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/15
02:29 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/7
02:07 am
aktx
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/5
06:33 pm
aktx
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AKTX, HES, TGAN, NS
Low
Report
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AKTX, HES, TGAN, NS
3/5
11:51 am
aktx
AKTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Akari Therapeutics, Plc Is Fair to Shareholders
Low
Report
AKTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Akari Therapeutics, Plc Is Fair to Shareholders
3/5
10:13 am
aktx
Akari Therapeutics rises on all-stock merger deal with Peak Bio [Seeking Alpha]
Medium
Report
Akari Therapeutics rises on all-stock merger deal with Peak Bio [Seeking Alpha]
3/5
08:10 am
aktx
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit [Yahoo! Finance]
Medium
Report
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit [Yahoo! Finance]
3/5
08:00 am
aktx
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Low
Report
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
3/5
08:00 am
aktx
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Low
Report
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit